Patienter, der får methadon og Atripla samtidigt, bør monitoreres for abstinenssymptomer, og deres methadondosis bør øges efter behov for at mildne abstinenssymptomerne.
Patients receiving methadone and Atripla concomitantly should be monitored for signs of withdrawal and their methadone dose increased as required to alleviate withdrawal symptoms.